Genotoxicity of the steroidal oestrogens oestrone and oestradiol: Possible mechanism of uterine and mammary cancer development

APMIS, Supplement

Volumn 109, Issue 103, 2001, Pages

  Liehr, J G ^a  

^a St Joseph's Medical Center Houston   (United States)

Author keywords

Genotoxicity; Mammary carcinogenesis; Oestrogen induced cancer; Oestrogen induced DNA damage; Oestrogen induced mutations

Indexed keywords

CARCINOGEN; CATECHOL ESTROGEN; DNA; ESTRADIOL; ESTROGEN; ESTRONE;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CELL STRAIN V 79; CHROMOSOME ABERRATION; CONFERENCE PAPER; DISEASE MODEL; DNA DAMAGE; EMBRYO; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENOTOXICITY; MICROSATELLITE INSTABILITY; NONHUMAN; ONCOGENE C MYC; POINT MUTATION; PRIORITY JOURNAL; TUMOR PROMOTION; UTERUS CANCER;

EID: 0034924790     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2001.tb05809.x     Document Type: Conference Paper

References (94)

1. An estrogen-nucleic acid adduct. Electroreductive inter-molecular coupling of 3,4-oestrone-o-quinone and adenine
2. Estrogen metabolism and excretion in oriental and Caucasian women
3. Microsomal hydroxylation of 2-and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: Catechol estrogens as possible mediators of hormonal carcinogenesis
4. Mutagenicity of methyl 2-benzimidazole carbamate, diethylstilbestrol and estradiol: Structural chromosomal aberrations, sister chromatid exchanges, c-mitoses, polyploidies and micronuclei
5. Cytogenetic changes in renal neoplasms and during estrogen-induced carcinogenesis
6. Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens
7. Mechanisms of estrogen-associated carcinogenesis
8. Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci
9. An MMTV-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-α
10. Mechanisms of tumor initiation by polycyclic aromatic hydrocarbons in mammals
11. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
12. Relating aromatic hydrocarbon-induced DNA adducts and c-Harvey-ras mutations in mouse skin papillomas: The role of apurinic sites
13. Dissociation between steroid receptor expression and cell proliferation in human breast
14. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
15. Formation of catechol estrogen adducts in kidneys of male hamsters treated with 4-hydroxyestradiol
16. Genotoxicity evaluation of estradiol
17. Mutagenicity assays of estrogenic hormones in mammalian cells
18. Nonrandom karyotypic changes in a spontaneously immortalized and tumorigenic Syrian hamster embryo cell line
19. Cell proliferation as a major risk factor for cancer: A concept of doubtful validity
20. Estrogens and breast cancer
21. Hormones as etiological agents in neoplasia
22. Sex hormones and postmenopausal breast cancer: A prospective study in an adult community
23. Endometrial cancer after menopausal use of estrogens
24. Aneuploidy of mouse cervicovaginal epithelium induced by perinatal estrogen treatment
25. DNA single strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens. Hormone-induced free radical damage preceding renal malignancy
26. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: Role of free radicals in estrogen-induced carcinogenesis
27. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: Correlation of DNA damage by free radicals with metabolic activation to quinones
28. Neoplastic and preneoplastic lesions induced in female C3H mice by diets containing diethylstilbestrol or 17β-estradiol
29. Osseous changes and osteosarcomas in mice continuously fed diets containing diethylstilbestrol or 17β-estradiol
30. Sister chromatid exchanges and cell division delays induced by diethylstilbestrol, estradiol, and estriol in human lymphocytes
31. Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolateral prostates of Noble rats
32. Estrogen-induced microsatellite DNA alterations are associated with Syrian hamster kidney tumorigenesis
33. Mechanisms, chemical carcinogenesis, and risk assessment: Cell proliferation and cancer
34. Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse
35. Protective effects of progesterone and tamoxifen in estrogen-induced mammary carcinogenesis in ovariectomized W/Fu rats
36. Hormonal contraception and postmenopausal hormone therapy
37. Covalent binding of ethinyl estradiol and estrone to rat liver DNA in vitro
38. The dose-effect relationship between 'unopposed' estrogens and endometrial mitotic rate: Its central role in explaining and predicting endometnal cancer risk
39. Estrogen-induced tumors of the kidney. III. Growth characteristics in the Syrian hamster
40. Frequency and molecular analysis of HPRT mutations induced by estradiol in Chinese hamster V79 cells
41. The role of the estrogen receptor in diethylstilbestrol toxicity
42. Non-mutagenicity of some sex hormones in the Salmonella/microsome test
43. Studies for a genotoxic potential of some endogenous and exogenous sex steroids. I. Communication: Examination for the induction of gene mutations using the Ames Salmonella/microsome test and the HGPRT test in V79 cells
44. Genetic instabilities in human cancers
45. Estrogen carcinogenesis in hamster tissues: Update
46. Estrogen carcinogenesis in hamster tissues: Role of metabolism
47. Estrogen carcinogenesis in hamster tissues: A critical review
48. Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: A probable critical role in neoplastic transformation
49. DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol
50. 2-Fluoroestradiol: Separation of estrogenicity from carcinogenicity
51. Is estradiol a genotoxic mutagenic carcinogen?
52. Inhibition of estrogen-induced renal carcinoma in Syrian hamsters by vitamin C
53. Cytochrome P-450-mediated redox cycling of estrogens
54. Carcinogenicity of catechol estrogens in Syrian hamsters
55. Hormonal carcinogenesis: Separation of estrogenicity from carcinogenicity
56. Estrogen-induced endogenous DNA adduction: Possible mechanism of hormonal cancer
57. Mechanism of inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by vitamin C
58. DNA adduct formation in liver and kidney of male Syrian hamsters treated with estrogen and/or α-naphthoflavone
59. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk
60. The etiology and prediction of breast cancer
61. Measurement of oxidative DNA damage by catechol estrogens and analogues in vitro
62. Long-term effects of progesterone or diethylstilbestrol with or without estrogen after maturity on mammary tumorigenesis in mice
63. Role of hormones in mammary neoplasia
64. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens
65. Spontaneous and estrogen-produced tumors in Nb rats and their behaviour after transplantation
66. Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells
67. An o-quinone form of estrogen produces free radicals in human breast cancer cells: Correlation with DNA damage
68. Exogenous hormones and breast cancer risk
69. The mutagenic potential of antiestrogens at the HPRT locus in V79 cells
70. Effect of hormone replacement therapy on breast cancer risk: Estrogen vs. estrogen plus progestin
71. Estrogen-nucleic acid adducts: Guanine is a major site for interaction between 3,4-estrone quinone and CO III gene
72. Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters
73. Pattern of distribution of cells positive for estrogen receptor α and progesterone receptor in relation to proliferating cells in the mammary gland
74. Carcinogenicity of estrogens in human breast epithelial cells
75. Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna
76. Reaction of the Premarin® metabolite 4-hydroxyequilin semiquinone radical with 2'-deoxyguanosine: Formation of unusual cyclic adducts
77. Alkylation of 2'-deoxynucleosides and DNA by the Premarin® metabolite 4-hydroxyequilenin semiquinone radical
78. Ovary intact, but not ovariectomized female ACI rats treated with 17β-estradiol rapidly develop mammary carcinoma
79. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides
80. Catecholestrogens as mediators of carcinogenesis: Correlation of aromatic hydroxylation of estradiol and its fluorinated analogs with tumor induction in Syrian hamsters
81. Mechanisms of gene inactivation by estrogens
82. Induction by estrogens of methotrexate resistance in MCF-7 breast cancer cells
83. A prospective study of endogenous estrogens and breast cancer in post-menopausal women
84. 17β-Estradiol-induced cell transformation and aneuploidy of Syrian hamster embryo cells in culture
85. Aneuploidy induction in human fibroblasts: Comparison with results in Syrian hamster fibroblasts
86. 17β-Estradiol, diethylstilbestrol, Tamoxifen, Toremifene and ICI 164,384 induce morphological transformation and aneuploidy in cultured Syrian hamster embryo cells
87. Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: Studies using Syrian hamster embryo cells treated with 17β-estradiol and eight of its metabolites
88. Induction of mammalian cell transformation and genotoxicity by 2-methoxyestradiol, anendogenous metabolite of estrogen
89. Lipid hydroperoxide-induced endogenous DNA adducts in hamsters: Possible mechanism of lipid hydroperoxide-mediated carcinogenesis
90. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues
91. Risk of endometrial cancer following estrogen replacement with and without progestins
92. Sex hormone levels in serum in relation to the development of breast cancer
93. The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites